Furthermore, functional studies in hepatocellular carcinoma reveal KAT2A’s involvement in suppressing tumor cell proliferation, inducing G1 phase cell cycle arrest, and promoting apoptotic pathways [16]. This evidence concerns the gene KAT2A and neoplasm.